APA (7th ed.) Citation
(2026). RETRACTION: Delanzomib, a Novel Proteasome Inhibitor, Sensitizes Breast Cancer Cells to Doxorubicin‐Induced Apoptosis. Thoracic Cancer.
Chicago Style (17th ed.) Citation
"RETRACTION: Delanzomib, a Novel Proteasome Inhibitor, Sensitizes Breast Cancer Cells to Doxorubicin‐Induced Apoptosis." Thoracic Cancer 2026.
MLA (9th ed.) Citation
"RETRACTION: Delanzomib, a Novel Proteasome Inhibitor, Sensitizes Breast Cancer Cells to Doxorubicin‐Induced Apoptosis." Thoracic Cancer, 2026.
Warning: These citations may not always be 100% accurate.